The FDA assessed the safety and usefulness of atidarsagene autotemcel based on data from 37 kids who gained atidarsagene autotemcel in two single-arm, open-label clinical trials As well as in an expanded access program.[7] Young children who been given treatment with atidarsagene autotemcel were being as compared to untreated children https://stevek913ikl7.wikinarration.com/user